Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Fifth Third Bancorp

Fifth Third Bancorp trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 32.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 119,384 shares of the pharmacy operator’s stock after selling 57,148 shares during the period. Fifth Third Bancorp’s holdings in Walgreens Boots Alliance were worth $3,117,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in Walgreens Boots Alliance by 14.5% during the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. Moneta Group Investment Advisors LLC boosted its position in Walgreens Boots Alliance by 84,503.5% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock worth $311,053,000 after purchasing an additional 8,315,989 shares during the period. Invesco Ltd. boosted its position in Walgreens Boots Alliance by 21.5% during the 3rd quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after purchasing an additional 3,013,807 shares during the period. BlackRock Inc. boosted its position in Walgreens Boots Alliance by 4.6% during the 1st quarter. BlackRock Inc. now owns 63,406,129 shares of the pharmacy operator’s stock worth $2,192,584,000 after purchasing an additional 2,797,885 shares during the period. Finally, Morgan Stanley boosted its position in Walgreens Boots Alliance by 15.8% during the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after purchasing an additional 1,720,228 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

WBA has been the subject of a number of analyst reports. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Bank of America lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research note on Tuesday, March 26th. Barclays initiated coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price for the company. Finally, Truist Financial restated a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research note on Monday. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $24.92.

Check Out Our Latest Stock Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $18.72 on Wednesday. Walgreens Boots Alliance, Inc. has a one year low of $18.67 and a one year high of $36.58. The stock has a 50-day simple moving average of $21.65 and a 200 day simple moving average of $22.26. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period last year, the firm earned $1.16 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 3.24 EPS for the current year.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett purchased 4,456 shares of the business’s stock in a transaction dated Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Insiders have acquired 20,456 shares of company stock valued at $458,473 over the last quarter. Insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.